Menu
Recruiting NCT02457962

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

— Observational Solid Tumors Hematologic Malignancies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Solid Tumors, Hematologic Malignancies. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Primary outcome measures

  • analyze acute and late toxicities using CTCAE 4.03 [Time frame: Patients will be followed for the duration of their life, an expected average of 20 years]
  • analyze quality of life using LASA-3 and FACT-E [Time frame: Patients will be followed for the duration of their life, an expected average of 20 years]
Secondary outcome measures (2)
  • analyze local control through tumor assessments [Time frame: Patients will be followed for the duration of their life, an expected average of 20 years]
  • analyze survival by contacting patient and EMR (electronic medical record) review [Time frame: Patients will be followed for the duration of their life, an expected average of 20 years]

Eligibility criteria

Inclusion criteria

  • Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology
  • Radiation therapy for curative intent

Exclusion criteria

None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United States · 1 center
  • Mayo Clinic — Rochester

Identifiers

NCT: NCT02457962 · 15-000136

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗